A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)

NCT03086460 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: CHF 1531 pMDI
DRUG: Formoterol Inhalation Solution
DRUG: Placebo pMDI

Sponsor

Chiesi Farmaceutici S.p.A.